American Oriental Bioengineering, Inc.
AOBI · OTC
9/30/2013 | 6/30/2013 | 3/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$21,177 | -$12,841 | -$21,115 | -$35,903 |
| Dep. & Amort. | $2,965 | $3,086 | $3,035 | $3,074 |
| Deferred Tax | $7 | $518 | $92 | $689 |
| Stock-Based Comp. | $420 | $318 | $561 | $690 |
| Change in WC | -$2,420 | $6,800 | $12,744 | -$17,234 |
| Other Non-Cash | $3,153 | -$903 | $2,830 | $39,371 |
| Operating Cash Flow | -$17,053 | -$3,021 | -$1,853 | -$9,314 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13,744 | -$1,018 | -$358 | -$13,292 |
| Net Acquisitions | $0 | $0 | $0 | $32 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $21 | $0 |
| Other Inv. Act. | $473 | -$258 | $4,208 | $2,634 |
| Investing Cash Flow | -$13,271 | -$1,276 | $3,871 | -$10,626 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $27,931 | $1,809 | -$5,061 | $427 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,069 | $1,095 | $3,364 | $531 |
| Financing Cash Flow | $25,862 | $2,904 | -$1,697 | $958 |
| Forex Effect | $688 | $1,982 | -$1,002 | -$353 |
| Net Chg. in Cash | -$3,774 | $589 | -$681 | -$19,335 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,005 | $6,416 | $7,097 | $26,432 |
| End Cash | $3,231 | $7,005 | $6,416 | $7,097 |
| Free Cash Flow | -$30,797 | -$4,039 | -$2,211 | -$22,605 |